|
NPPA revises ceiling price of six formulations based on DoP's review order
|
|
Gireesh Babu, New Delhi
November 20 , 2024
|
|
|
The National Pharmaceutical Pricing Authority (NPPA) has revised the ceiling price calculation of six formulations based on review orders passed in favour of various companies in the month of October this year.
The formulations for which the ceiling prices were revised based on review orders include local anesthetic drugs lignocaine injection 2% and lignocaine topical forms 2-5% per gm, antibiotic drugs clarithromycin 250mg and clarithromycin oral liquid 125mg per 5ml, and vitamin supplements ascorbic acid (vitamin C) 500 mg, and thiamine injection 100 mg/ml.
The ceiling price of lignocaine injection 2 per cent has been revised from Rs. 1.04 per ml, notified in March 26, 2024 to Rs. 1.14 per ml. Neon Laboratories has alleged that the authority has earlier erred in ceiling price calculation and its product Lox Viscous 2% should not have been included in calculation of the price for lignocaine injection 2% per ml.
Ceiling price of lignocaine topical forms 2-5% per gm or per ml was revised from Rs. 1.13 per gm per ml to Rs. 1.08 per gm per ml, now.
Ceiling price of clarithromycin 250mg has been revised from the current price of Rs. 23.89 per tablet to Rs. 24.06 per tablet. This was following another review order by the Department of Pharmaceuticals (DoP) on October 4, 2024, which referred back the price revision for recalculation. Abbott approached the review authority alleging that the price regulator did not consider the revised price to retailer of brand Maclar from Glenmark Pharmaceuticals while calculating the ceiling price.
Ceiling price of clarithromycin oral liquid 125mg per 5ml was revised from the current ceiling price of Rs. 4.61 per ml to Rs. 4.65 per ml, after the DoP issuing an order on October 4, in favour of Cipla Ltd. Cipla approached the DoP for review order, alleging that its correction in Price to Retailer for its brand Synclar 125 mg dry syrup 30 ml was not made in the calculation of the ceiling price by the NPPA. The PTR of the formulation was revised to Rs. 112.80 while the NPPA calculated the price of Rs. 101.95, it alleged.
Price of ascorbic acid (vitamin C) 500 mg was revised based on an order by the DoP on October 4, 2024, in favour of Koye Pharmaceuticals, which sells the drug under the brand Celin 500 tablet. According to NPPA, the current ceiling price is Rs. 1.48 per tablet, which is revised to Rs. 1.54 per tablet. The company argued at the PTR reflected in Pharmatrac, the database on which the NPPA relies for pricing decisions, for its brand and Abbott Healthcare's Limcee tablets were erroneous. Besides, the PTR considered by NPPA for calculation did not include the impact of Wholesale Price Index (WPI) applicable from April 1, 2022, it added.
Ceiling price of thiamine injection 100 mg/ml has been revised from the current price of Rs. 22.59 per ml to Rs. 26.70 per ml based on a review order by the DoP in favour of Ordain Health Care Global, on October 4, 2024.
The Department of Pharmaceuticals (DoP) has referred the ceiling price fixation of vitamin product Thiamin 100 mg injection 2 ml containing thiamine 100 mg per ml from Ordain Health Care Global, back to the price regulator for recalculation after identifying that a fixed dose combination of another company was considered in the previous calculation.
It may be noted that the DoP has issued orders on several review applications submitted by individual firms, including Pfizer, AstraZeneca, Abbott Healthcare, Cipla, Lupin and others during the month of October.
|
|
|
|
|
|
|
|
TOPICS
|
That foods might provide therapeutic benefits is clearly not a new concept. ...
|
|
|
|
|